Eastern Asia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Eastern Asia

The East Asian prophylactic medicaments containing insulin market rose sharply to $X in 2022, increasing by 6% against the previous year. Over the period under review, consumption showed a strong expansion. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Eastern Asia

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Overall, production enjoyed prominent growth. The growth pace was the most rapid in 2013 with an increase of 42%. Over the period under review, production reached the maximum level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Eastern Asia

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported in Eastern Asia; dropping by -13% compared with the year before. Overall, exports, however, recorded a significant expansion. The growth pace was the most rapid in 2013 when exports increased by 166% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2021, and then shrank in the following year.

In value terms, prophylactic medicaments containing insulin exports fell rapidly to $X in 2022. In general, exports, however, saw significant growth. The pace of growth was the most pronounced in 2013 when exports increased by 230% against the previous year. The level of export peaked at $X in 2021, and then dropped sharply in the following year.

Exports by Country

China (X tons) represented roughly 99% of total exports in 2022.

China was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of +44.4% from 2012 to 2022. While the share of China (+18 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) also remains the largest prophylactic medicaments containing insulin supplier in Eastern Asia.

In China, prophylactic medicaments containing insulin exports expanded at an average annual rate of +50.7% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in Eastern Asia amounted to $X per ton, declining by -8.5% against the previous year. Export price indicated a temperate expansion from 2012 to 2022: its price increased at an average annual rate of +4.8% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price decreased by -13.1% against 2020 indices. The most prominent rate of growth was recorded in 2020 when the export price increased by 37%. As a result, the export price reached the peak level of $X per ton. From 2021 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for China.

From 2012 to 2022, the rate of growth in terms of prices for China amounted to +4.4% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Eastern Asia

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported in Eastern Asia reduced dramatically to X tons, shrinking by -23% compared with the year before. Over the period under review, imports, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2013 with an increase of 20%. Over the period under review, imports reached the peak figure at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports fell dramatically to $X in 2022. Overall, imports recorded a abrupt contraction. The most prominent rate of growth was recorded in 2021 with an increase of 12% against the previous year. The level of import peaked at $X in 2013; however, from 2014 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Japan (X tons), China (X tons) and South Korea (X tons) was the major importer of medicaments containing insulin but not antibiotics in measured doses in Eastern Asia, committing 90% of total import. Taiwan (Chinese) (X tons) took the next position in the ranking, followed by Hong Kong SAR (X tons). All these countries together held approx. 9.8% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Taiwan (Chinese) (with a CAGR of +14.2%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Japan ($X), China ($X) and South Korea ($X) constituted the countries with the highest levels of imports in 2022, with a combined 92% share of total imports. Taiwan (Chinese) and Hong Kong SAR lagged somewhat behind, together accounting for a further 7.7%.

Hong Kong SAR, with a CAGR of +9.8%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Eastern Asia amounted to $X per ton, which is down by -26.5% against the previous year. Over the period under review, the import price saw a deep reduction. The pace of growth was the most pronounced in 2021 when the import price increased by 11% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was China ($X per ton), while South Korea ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Korea (+2.9%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :